Ariizumi K - Search Results

1

DC-HIL+ CD14+ HLA-DR no/low cells are a potential blood marker and therapeutic target for melanoma.

Turrentine J, Chung JS, Nezafati K, Tamura K, Harker-Murray A, Huth J, Sharma RR, Harker DB, Ariizumi K, Cruz PD Jr. Turrentine J, et al. Among authors: ariizumi k. J Invest Dermatol. 2014 Nov;134(11):2839-2842. doi: 10.1038/jid.2014.248. Epub 2014 Jun 16. J Invest Dermatol. 2014. PMID: 24933321 Free PMC article. No abstract available.

2

DC-HIL-expressing myelomonocytic cells are critical promoters of melanoma growth.

Chung JS, Tamura K, Cruz PD Jr, Ariizumi K. Chung JS, et al. Among authors: ariizumi k. J Invest Dermatol. 2014 Nov;134(11):2784-2794. doi: 10.1038/jid.2014.254. Epub 2014 Jun 17. J Invest Dermatol. 2014. PMID: 24936834 Free PMC article.

3

Myeloid-Derived Suppressor Cells in Psoriasis Are an Expanded Population Exhibiting Diverse T-Cell-Suppressor Mechanisms.

Cao LY, Chung JS, Teshima T, Feigenbaum L, Cruz PD Jr, Jacobe HT, Chong BF, Ariizumi K. Cao LY, et al. Among authors: ariizumi k. J Invest Dermatol. 2016 Sep;136(9):1801-1810. doi: 10.1016/j.jid.2016.02.816. Epub 2016 May 25. J Invest Dermatol. 2016. PMID: 27236103 Free PMC article.

4

Melanoma-Derived Soluble DC-HIL/GPNMB Promotes Metastasis by Excluding T-Lymphocytes from the Pre-Metastatic Niches.

Ramani V, Teshima T, Tamura K, Chung JS, Kobayashi M, Cruz PD Jr, Ariizumi K. Ramani V, et al. Among authors: ariizumi k. J Invest Dermatol. 2018 Nov;138(11):2443-2451. doi: 10.1016/j.jid.2018.05.012. Epub 2018 May 30. J Invest Dermatol. 2018. PMID: 29857071 Free article.

5

Soluble DC-HIL/Gpnmb Modulates T-Lymphocyte Extravasation to Inflamed Skin.

Ramani V, Chung JS, Ariizumi K, Cruz PD Jr. Ramani V, et al. Among authors: ariizumi k. J Invest Dermatol. 2022 May;142(5):1372-1380.e5. doi: 10.1016/j.jid.2021.10.004. Epub 2021 Oct 23. J Invest Dermatol. 2022. PMID: 34695414 Free article.

6

Identification and expression profiling of a human C-type lectin, structurally homologous to mouse dectin-2.

Gavino AC, Chung JS, Sato K, Ariizumi K, Cruz PD Jr. Gavino AC, et al. Among authors: ariizumi k. Exp Dermatol. 2005 Apr;14(4):281-8. doi: 10.1111/j.0906-6705.2005.00312.x. Exp Dermatol. 2005. PMID: 15810886 Free article.

7

DC-HIL is a negative regulator of T lymphocyte activation.

Chung JS, Sato K, Dougherty II, Cruz PD Jr, Ariizumi K. Chung JS, et al. Among authors: ariizumi k. Blood. 2007 May 15;109(10):4320-7. doi: 10.1182/blood-2006-11-053769. Epub 2007 Feb 6. Blood. 2007. PMID: 17284525 Free PMC article.

8

Syndecan-4 mediates the coinhibitory function of DC-HIL on T cell activation.

Chung JS, Dougherty I, Cruz PD Jr, Ariizumi K. Chung JS, et al. Among authors: ariizumi k. J Immunol. 2007 Nov 1;179(9):5778-84. doi: 10.4049/jimmunol.179.9.5778. J Immunol. 2007. PMID: 17947650

9

Gpnmb is a melanosome-associated glycoprotein that contributes to melanocyte/keratinocyte adhesion in a RGD-dependent fashion.

Tomihari M, Hwang SH, Chung JS, Cruz PD Jr, Ariizumi K. Tomihari M, et al. Among authors: ariizumi k. Exp Dermatol. 2009 Jul;18(7):586-95. doi: 10.1111/j.1600-0625.2008.00830.x. Epub 2009 Mar 6. Exp Dermatol. 2009. PMID: 19320736 Free PMC article.

10

The DC-HIL/syndecan-4 pathway inhibits human allogeneic T-cell responses.

Chung JS, Bonkobara M, Tomihari M, Cruz PD Jr, Ariizumi K. Chung JS, et al. Among authors: ariizumi k. Eur J Immunol. 2009 Apr;39(4):965-74. doi: 10.1002/eji.200838990. Eur J Immunol. 2009. PMID: 19350579 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

97 results

Search Page

Filters